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Abstract. We report on the detailed NMR spectral analyses of amino- or/and hydroxy-
substituted benzoic acids: anthranilic (AA), 3-hydroxyanthranilic (3-HAA), 5-
hydroxyanthranilic (5-HAA), salicylic (SA), 4-aminosalicylic (4-ASA) and 5-aminosalicylic 
(5-ASA) acids. According to a literature survey, there are limited, unassigned or even 
incorrectly assigned spectral data to these benzoic acid derivatives. In order to amend the 
situation, a complete assignment of 1H- and 13C-NMR spectra of these compounds, 
recorded in perdeuteriodimethyl sulfoxide (DMSO-d6), based on a combination of 1D- 
and 2D-NMR experiments, including 1H-1H COSY, NOESY, HSQC and HMBC, was 
performed. 
Key words: 1H- and 13C-NMR, 1D- and 2D-NMR, anthranilic acid, 3- and  
5-hydroxyanthranilic acids, salicylic acid, 4- and 5-aminosalicylic acids 
1. INTRODUCTION 
Salicylic and anthranilic acids (Fig. 1) are simple benzoic acids with a hydroxyl- or 
amino-group in the ortho-position, respectively. Salicylic (2-hydroxybenzoic) acid (SA) is 
a plant metabolite well-known for its ability to ease aches and pains and reduce fevers, 
and it is used as an anti-inflammatory drug (Madan and Levitt, 2014). It is an active 
metabolite of salicin, a glycoside isolated from Salix alba, a plant species used since 
ancient times to provide relief from pain and inflammation. Furthermore, it is an 
important active metabolite of aspirin (acetylsalicylic acid), a widely used non-steroidal 
anti-inflammatory drug (Delaney, 2010). Salicylic acid is a keratolytic agent (WHO, 
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1997) and, like other hydroxy acids, it is a key ingredient in many skin-care products for 
the treatment of seborrheic dermatitis, acne, psoriasis, calluses, corns, keratosis pilaris, 
acanthosis nigricans, ichthyosis, and warts (Madan and Levitt, 2014). It is widely used in 
organic synthesis and functions as a plant hormone (Raskin, 1992). 
Two amino derivatives of salicylic acid, 4-aminosalicylic acid (para-aminosalicylic 
acid, 4-ASA or PAS) and 5-aminosalicylic acid (5-ASA) (Fig. 1) are used to treat 
inflammatory bowel diseases, such as ulcerative colitis and mild-to-moderate Crohn's 
disease (Kruis et al., 2001; Sandborn et al., 2007; Daniel et al., 2004). As derivatives of 
salicylic acid, they are thought to possess significant antioxidant potential (Simmonds et 
al., 1999). 4-ASA is an antibiotic drug used to treat tuberculosis (Fox et al., 1999), while 
5-ASA is an anti-inflammatory drug, sold under the name mesalazine (INN, BAN) or 
mesalamine (USAN) ("Mesalazine", PharmGKB). 
Anthranilic (2-aminobenzoic) acid (AA) is an intermediary metabolite in the 
anabolism and catabolism of tryptophan (Wiklund and Bergman, 2006). Industrially, it is 
an intermediate in the production of azo dyes, pigments and saccharin (Wiklund and 
Bergman, 2006; Wouters and Quéré, 2011) and alongside its esters, it is used in preparing 
perfumes (to imitate jasmine and orange), pharmaceuticals (loop diuretics e.g. 
furosemide) and as a UV-absorber (Wouters and Quéré, 2011). 
3-Hydroxyanthranilic (3-HAA) and 5-hydroxyanthranilic acids (5-HAA) (Fig. 1) are 
also metabolites of tryptophan and they could form either by monooxygenation of AA or 
from 3- or 5-hydroxy-L-kynurenine (Fujigaki et al., 1998). They are neurotoxics (Smith et 
al., 2009; Krause et al., 2011) and hypoglycemic agents (Armarego and Chai, 2003). 3-
HAA induces macrophage/monocyte apoptosis under certain conditions, which may be 
relevant to pathophysiology of inflammatory conditions (Morita et al., 1999). It has been 
shown to inhibit nitric oxide synthase expression and activity in macrophages (Sekai et 
al., 1997). Moreover, 3-HAA may be a free radical scavenger and a carcinogen (Boyland 
and Watson, 1956). 
 
Fig. 1 Structures of the investigated compounds: anthranilic (AA),  
3-hydroxyanthranilic (3-HAA), 5-hydroxyanthranilic (5-HAA), salicylic (SA),  
4-aminosalicylic (4-ASA), 5-aminosalicylic (5-ASA) acids 
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Recently, we have identified a new natural anthranilic acid derivative – isopropyl N-
methylanthranilate (ternanthranin), and a related compound, methyl N-methylanthranilate 
from the essential oil of Choisya ternata Kunth, a plant species used in Mexican folk 
medicine (Radulović et al., 2011). These two N-methylanthranilic acid esters were 
demonstrated to possess a number of important pharmacological properties: peripheral 
and central antinociceptive activity (Radulović et al., 2011; Gomes Pinheiro et al., 2014), 
anti-inflammatory activity (Gomes Pinheiro et al., 2015), anxiolytic and antidepressant 
potential, the effect on the onset and duration of diazepam-induced sleep (Radulović et 
al., 2013a), as well as nephro-(Radulović et al., 2015), hepato- (Radulović et al., 2013b) 
and gastro- (Radulović et al., 2013c) protective activities. In the continuation of our 
investigations on anthranilic (ortho-aminobenzoic) acid derivatives and considering the 
importance of the before mentioned amino- or/and hydroxy-substituted benzoic acids, we 
decided to analyze in detail 
1
H- and 
13
C-NMR spectra of AA, 3- and 5-HAA, SA, 4- and 
5-ASA, recorded in perdeuteriodimethyl sulfoxide (DMSO-d6). Although NMR spectral 
data for these compounds are available in the literature (Regulska et al., 2009; Esaki et al., 
1996; Rajkumar et al., 2012; Jadrijević-Mladar Takac and Vikić Topić, 2004; da Silva et 
al., 2008; Peng et al., 2004) or from commercial sources (BIORAD; WSS; ACD), the 
reported studies provided limited and often unassigned data, or where assignation was 
attempted, it was based solely on “chemical” logic and not on the use of 2D NMR spectra. 
Moreover, the 
13
C-
1
H coupling constants are often absent from the existing reports, 
probably due to the duration of the recording of such coupled 
13
C NMR spectra. To 
address the paucity of fully assigned NMR spectral data for these compounds, 
1
H- and 
13
C-NMR spectral data were fully assigned based on a combination of 1D- and 2D- NMR 
experiments (
1
H-
1
H COSY, NOESY, HSQC and HMBC). Also the substituent effects on 
the spectral properties of these benzoic acid derivatives were discussed. 
2. EXPERIMENTAL 
All the compounds were commercially available and were used as received. The purity 
was higher than 99.9% according to GC–MS (on a Hewlett-Packard 6890N gas 
chromatograph equipped with a fused silica capillary column DB-5MS) and/or NMR 
analyses. 
All NMR spectra were recorded at 25 °C using perdeuteriodimethyl sulfoxide 
(DMSO-d6) as the solvent with tetramethylsilane (TMS, Me4Si) as an internal standard. 
Chemical shifts are expressed in δ (ppm) and referenced to TMS (δH = 0 ppm) in 
1
H NMR 
spectra or to DMSO-d6 (δH = 2.50 ppm, δC = 39.52 ppm) in 
13
C NMR and heteronuclear 
2D spectra. Scalar couplings are reported in Hertz. Typically, 20 mg of sample was 
dissolved in 1 ml of DMSO-d6, and 0.7 ml of the solution transferred into a 5 mm 
Wilmad, 528-TR-7 NMR tube. 
The 
1
H- and 
13
C-NMR spectra of AA, 3- and 5-HAA, SA, 4- and 5-ASA were 
recorded on a Bruker Avance III 400 MHz NMR spectrometer (
1
H at 400 MHz, 
13
C at 
100 MHz), equipped with a 5-mm dual 
13
C/
1
H probe head. The 
1
H spectra were recorded 
with 16 scans, 1 s relaxation delay, 4 s acquisition time, 0.125 Hz digital FID resolution, 
51 280 FID size, with 6410 Hz spectral width, and an overall data point resolution of 
0.0003 ppm. The 
13
C spectra were recorded with Waltz 161H broadband decoupling, 
1024 scans, 0.5 s relaxation delay, 1 s acquisition time, 0.5 Hz digital FID resolution, 65 
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536 FID size, 31 850 Hz spectral width, and an overall data point resolution of 0.005 
ppm. The DEPT-135 and DEPT-90 spectra were recorded by the standard Bruker Pulse 
Program Dept135 and Dept90 with 256 scans, respectively. The relaxation delay for each 
above measurement was 2 s. 
Standard pulse sequences were used for 2D spectra. 
1
H-
1
H COSY and NOESY spectra 
were recorded at spectral widths of 5 kHz in both F2 and F1 domains; 1 K × 512 data 
points were acquired with 32 scans per increment and the relaxation delays of 2.0 s. The 
mixing time in NOESY experiments was 1 s. Data processing was performed on a 1K × 
1K data matrix. Inverse-detected 2D heteronuclear correlated spectra were measured over 
512 complex points in F2 and 256 increments in F1, collecting 128 (HSQC) or 256 
(HMBC) scans per increment with a relaxation delay of 1.0 s. The spectral widths were 5 
and 27 kHz in F2 and F1 dimensions, respectively. The HSQC experiments were 
optimized for C–H couplings of 160 Hz; the HMBC experiments were optimized for 
long-range C–H couplings of 10 Hz. Fourier transforms were performed on a 512 × 512 
data matrix. π/2. Shifted sine-squared window functions were used along F1 and F2 axes 
for all 2D spectra. 
3. RESULTS AND DISCUSSION 
The NMR spectra of anthranilic acid and its 3- and 5-hydroxy derivatives, as well as 
salicylic acid and its 4- and 5-aminoderivatives were recorded in DMSO-d6 (Fig. 1). The 
1
H- and 
13
C-NMR data are summarized in Tables 1 and 2. Chemical shifts, multiplicities 
and the observed coupling constants were in accordance with the structure of the 
investigated acids. The number of carbon signals corresponded to the expected number of 
carbon atoms of the investigated compounds, while the DEPT90/135 spectra showed only 
the existence of CH groups among protonated carbons. The 
13
C-
1
H coupling constants, 
previously unavailable in the literature, were derived from the proton-coupled 
13
C NMR 
spectra. A number of resolved long-range coupling constants (two-and three-bond 
couplings) alongside one-bond coupling of directly attached carbon and hydrogen atoms 
were observable in these spectra (Table 2). 
Table 1 
1
H NMR (400 MHz) spectral data (DMSO-d6) for AA, 3- and 5-HAA, SA, 4- and 5-ASA 
1
H NMR, δ (ppm), multiplicity (J in Hz) 
H atom AA 3-HAA 5-HAA SA 4-ASA 5-ASA 
H-3 6.74, dd 
(8.4, 1.0) 
- 6.61, d 
(8.8) 
6.97, dd 
(8.6, 0.9) 
5.98, d 
(2.1) 
6.70, 
d (8.7) 
H-4 7.22, ddd 
(8.4, 7.0, 1.6) 
6.81, dd 
(7.6, 1.5) 
6.78, dd 
(8.8, 2.9) 
7.52, ddd 
(8.6, 7.1, 
1.7) 
- 6.90, 
dd (8.7, 2.9) 
H-5 6.50, ddd 
(8.1, 7.0, 1.0) 
6.38, dd 
(8.2, 7.6) 
- 6.93, ddd 
(7.9, 7.1, 
0,9) 
6.10, dd 
(8.7, 2.1) 
- 
H-6 7.69, dd 
(8.1, 1.6) 
7.22, dd 
(8.2, 1.5) 
7.11, d 
(2.9) 
7.82, dd 
(7.9, 1.7) 
7.43, d 
(8.7) 
7.20, 
d (2.9) 
-COOH 8.58, br s, 
3H* 
8.18, br s, 3H 
9.57, br s, 1H 
8.16, br s, 3H 
8.60, br s, 1H 
11.64, br s, 
2H** 
6.03, br s, 2H 
11.42, br s, 1H 
12.36, br s, 1H 
6.41, br s, 4 H 
-OH 
-NH2 
*No –OH group present in the molecule; ** No –NH2 group present in the molecule. 
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Table 2 13C NMR (100 MHz) spectral data (DMSO-d6) for AA, 3- and 5-HAA, SA, 4- and 5-ASA 
13C NMR, δ (ppm), multiplicity (J in Hz) 
C atom AA 3-HAA 5-HAA SA 4-ASA 5-ASA 
C-1 109.6 C, ddd 
(3J = 8.0, 5.4, 
 2J = 1.8) 
110.0 C, d 
(3J = 8.8) 
110.0 C, d 
(3J = 6.4) 
113.1 C, dd 
(3J = 7.4, 5.6) 
100.1 C, dd 
(3J = 7.7, 5.0) 
114.3 C, d 
(3J = 4.7) 
C-2 151.5 C, pseudo t 
(3J = 7.7) 
141.1 C, pseudo t 
(3J = 6.7) 
144.8 C, dd 
(3J = 8.5, 7.0) 
161.2 C, m 163.5 C, dd 
(3J = 8.4,  
2J = 3.0) 
154.7 C, m 
C-3 116.4 CH, dd 
(1J = 162.7,  
3J = 8.1) 
144.5 C, dd 
(3J = 9.7, 2J = 1.4) 
117.7 CH, d 
(1J = 159.7) 
117.1 CH, dd 
(1J = 161.6, 3J = 7.6) 
98.6 CH, dd 
(1J = 157.9,  
3J = 4.8) 
117.1 CH, 
m* 
(1J = 160.4) 
C-4 133.8 CH, ddd 
(1J = 157.6,  
3J = 9.1, 2J = 1.4) 
116.7 CH, ddd 
(1J = 156.4, 
 3J = 9.0, 2J = 1.5) 
123.1 CH, dd 
(1J = 158.9,  
3J = 5.9) 
135.6 CH, ddd 
(1J = 159.9,  
3J = 9.1, 2J = 1.5) 
155.8 C, br d 
(3J = 10.2) 
123.7 CH, 
m* 
(1J = 157.1) 
C-5 114.6 CH, dd 
(1J = 162.7,  
3J = 8.1) 
114.0 CH, d 
(1J = 161.2) 
146.6 C, 
pseudo dt 
(3J = 9.9, 
 2J = 3.1) 
119.2 CH, dd 
(1J = 163.6, 3J = 8.0) 
106.3 CH, dd 
(1J = 161.0,  
3J = 5.5) 
136.1 C, m 
C-6 131.2 CH, ddd 
(1J = 159.9,  
3J = 7.8, 2J = 1.4) 
121.4 CH, ddd 
(1J = 162.0,  
3J = 8.0, 2J = 1.4) 
115.3 CH, dd 
(1J = 158.8, 
 3J = 4.7) 
130.3 CH, ddd 
(1J = 162.3, 
 3J = 8.4, 2J = 1.4) 
131.5 CH, br d 
(1J = 159.6) 
116.1 CH, d 
(1J = 159.8) 
COOH 169.6 C, br d 
(3J = 3.8) 
169.8 C, br d 
(3J = 3.6) 
169.4 C, dd 
(3J = 4.4, 
 5J = 1.5) 
172.0 C, br d 
(3J = 3.9) 
172.1 C, br d 
(3J = 3.5) 
171.8 C, dd 
(3J = 4.3,  
5J = 1.3) 
m*  second-order multiplets, where it was only possible to determine one-bond 13C-H coupling (Fig. 4). 
The assignation of all proton and carbon-13 NMR signals was made possible only by 
the use of 2D NMR (
1
H–1H COSY, NOESY, HSQC and HMBC spectra) and correlations 
observed in these spectra gave rise to the assignations given in Tables 1 and 2. For 
example, the chemical shifts of non-protonated carbons C-2 and C-5 of 5-HAA were 
inferred from the HMBC spectrum due to the existence of cross-peaks between H-3 at 
6.61 and H-4 at 6.78 ppm and carbons at 144.8 and 146.6 ppm (Fig. 2). A coupling 
between a carbon and a proton of an aromatic core through three bonds is stronger than a 
coupling through two bonds. As the cross-peak between H-4 and the carbon at 144.8 ppm 
was more intense than the one between H-4 and C-atom at 146.6 ppm, and the intensity of 
the cross-peak between H-3 and carbon at 146.6 was higher than the one between H-3 and 
the carbon signal at 144.8 ppm, the signal at 144.8 ppm was assigned to C-2, while the 
one at 146.6 was assigned to C-5. This assignment was additionally corroborated by the 
analysis of 
1
H-coupled 
13
C NMR spectra. The carbon signal at 144.8 ppm appeared as a 
doublet of doublets (dd) with coupling constants of 8.5 and 7.0 Hz, which was indicative 
of a carbon atom that has two meta-protons, while the carbon signal at 146.6 ppm 
appeared as a pseudo doublet of triplets (pseudo dt) with the 
13
C-H coupling constants 9.9 
and 3.1 Hz, 
3
J and 
2
J, respectively. 
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Fig. 2 Expansions (
1
H: 6.5-7.2; 
13
C: 105-175 ppm) of the HMBC spectrum of 5-HAA 
The location of exchangeable protons (-COOH, -NH2 and/or -OH) was revealed from 
a careful inspection of the NOESY spectra of the investigated acids. For example, the 
NOESY spectrum of 4-ASA is shown in Fig. 3. The cross-peaks originating from the 
dipolar coupling of H-5 and H-6, protons that are in close proximity one to each other, are 
distinguished from (chemical) exchange cross-peaks by their opposite phases. The 
opposite phases are represented in different colors in the spectrum. Dipolar coupling is 
represented in blue, while the cross-peaks originating from the coupling of exchangeable 
protons and diagonal (auto) peaks are depicted in orange color. A peak originating from 
residual water (atmospheric moisture) at about 3.4 ppm could be observed in the 
1
H NMR 
spectra of all investigated compounds (except SA and 5-ASA) and the NOESY spectra of 
these compounds displayed cross-peaks between the exchangeable protons and the water 
signal. 
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Fig. 3 NOESY spectrum of 4-ASA 
Chemical shifts of C-1 of hydroxy derivatives of anthranilic acid (3-HAA – 110.0 
ppm, 5-HAA – 110.0 ppm) were close in value to that of anthranilic acid (109.6 ppm). On 
the other hand, the chemical shifts of C-1 of 4-ASA (100.1 ppm) were shifted towards 
lower values in comparison with the one of SA (113.1 ppm) and 5-ASA (114.3 ppm). As 
the electron donating hydroxyl group in 3-HAA and 5-HAA is meta- to C-1, it is not 
expected to significantly influence the electron density at C-1 and consequently its δ 
value. In general, as expected, both –OH and –NH2 groups altered (increased) the electron 
density of carbon atoms in the ortho- and para-positions relative to either of them. This 
resulted in a shielding effect and moving of the corresponding carbon resonances to 
higher field in comparison with AA and SA. The meta-positioned carbons relative to –OH 
and –NH2 groups showed no significant influence from the presence of the two electron-
donating groups and displayed similar chemical shifts to those of AA and SA. The 
interchange between amino- and hydroxyl-groups, as in the pair of AA and SA, as well as 
the pair of 5-HAA and 5-ASA, does not influence significantly the value of the chemical 
shift of core carbons except for the carbon directly attached to the group. This suggests a 
similar electron donating capacity of the two groups, and the greatest deviations can be 
observed for the para-positioned carbon in respect to the –NH2 or –OH groups (up to 5 
ppm). 
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The carboxylic carbon atom resonated at around 170 ppm in the 
13
C NMR of 
anthranilic acid and its 3- and 5-hydroxy derivatives, while the spectra of salicylic acid 
and its 4- and 5-amino derivatives displayed the resonance of this carbon at somewhat 
lower field (around 172 ppm). This carbon appeared as a broad doublet, with a coupling 
constant of around 4 Hz, except in the case of 5-HAA and 5-ASA, where this broad signal 
was resolved into a doublet of doublets with coupling constants of ca. 4 (
3
J coupling to H-
6) and 1.5 Hz (
4
J, i.e. “W”, coupling to H-3). The mentioned resolution originates from 
the lack of additional long-range coupling between H-5 and –COOH in 5-substituted 
derivatives. One could expect a similar resolution of –COOH signal in 3-HAA. Although 
the width at half-height of this signal did decrease (compared to the analogous signal from 
AA), for some 1.5 Hz, due to the lack of 
3
J with H-3, it did not result in any significant 
signal resolution. These values of 
13
C-H coupling constants were in accordance with the 
literature values (Ihrig et al., 1972). 
Furthermore,
 13
C-H coupling constants of the investigated benzoic acids showed the 
following trends: (1) 
3
JCH couplings are larger (6–12 Hz) than the 
2
JCH couplings (0–4 Hz) 
and easier to discern (in the case of 3-HAA, C-4 displayed a three-bond coupling of 9 Hz to 
H-6, and a coupling constant of 1.5 Hz to H-5 through two bonds); (2) The magnitude of the 
3
JCH couplings are directly proportional to the increased electronegativity of the substituent 
(in the case of AA, J(C-6-H-4) = 7.8 Hz, while in SA, J(C-6-H-4) increased to 8.4 Hz); (3) If 
a substituent is on the coupling pathway, the 
3
J values decrease with increased 
electronegativity (in the case of 3-HAA, J(C-4-H-6) = 9.0 Hz, while in 5-HAA, J(C-4-H-6) 
decreased to 5.9 Hz). This is in agreement with other di- or tri-substituted aromatic systems 
(DiMichele et al., 2006, and references cited therein). 
In the proton-coupled 
13
C NMR spectrum of 5-ASA, the signals at 117.1 ppm and 
123.7 ppm, assigned to C-3 and C-4, respectively, appeared as asymmetric multiplets 
which indicated that they represented second-order multiplets, although initially first-
order ones were expected (Fig. 4). The high-field parts of the multiplets arising from one 
bond and longer-range couplings differed from the low-field halves. Interestingly, the 
protons directly attached to the two mentioned carbons displayed first-order signals. 
Douglas and Shapiro (1980) reported that “unexpected” second-order effects could be 
encountered even when the relative proton shifts are large compared to proton-proton 
coupling constants. One could regard C-3-H-3-H-4 and C-4-H-4-H-3 as two ABX systems 
due to the near equality of the relative proton shift, in frequency units, to the difference 
between one-bond and long-range 
13
C-H couplings. The appearance of strong second-
order features when 1/2|υA – υB| is nearly equal to 1/4|J(AX) – J(BX)| is to be expected 
whenever J(AB) is as large as a few Hz (Douglas and Shapiro, 1980). Since in our case 
1/2|υH-3  – υH-4| = 39.6 Hz, according to 1/4|J(H-3-C-3) – J(H-4-C-3)| = 39.6 Hz, and 
knowing that J(H-3-C-3) = 160.4 Hz, we could estimate the value of J(H-4-C-3) to be 
around 2 Hz, what is in agreement with the values of the corresponding two-bond 
couplings found in the other herein investigated derivatives. 
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Fig. 4 Second-order multiplets (signals corresponding to C-3, up, and C-4, down, at 117.1 and 
123.7 ppm, respectively) observed in the proton-coupled 
13
C NMR of  
5-ASAA literature survey (SciFinder search of the CAS database) on the NMR data of 
these amino- or/and hydroxy-substituted benzoic acids revealed the following: 
130 A. MILTOJEVIĆ, N. RADULOVIĆ 
1) Interestingly, the NMR spectra of AA recorded in DMSO-d6 were very similar to 
1
H- and 
13
C-spectral data for AA in D2O (Regulska et al., 2009); however, the 
signals of C-3 and C-5 appear to be interchanged. 
2) 1H- and 13C-spectral data for 3-HAA were in accordance with Esaki et al. (1996) 
and Rajkumar et al. (2012); although Esakai with his coworkers did not report the 
chemical shifts of exchangeable protons, while in the 
1
H NMR spectrum recorded 
by Rajkumar et al. all exchangeable protons resonated at the same δ. 
3) NMR data for 5-HAA are available only from commercial sources (BIORAD, 
WSS, ACD), but since not being the subject of a scientific investigation, they 
were not assigned. 
4) 1H- and 13C-spectral data for SA were in accordance with Jadrijević-Mladar 
Takac and Vikić Topić (2004). 
5) Da Silva et al. (2008) reported the following NMR data for 4-ASA: 1H NMR: δ = 
7.93 (s, J = 8.5 Hz, 2H), 7.80 (d, J = 8.5 Hz, 1H), 7.00 (dd, J = 8.5, 1.8 Hz, 1H), 
7.08 (d, J = 8.5 Hz, 1H), 6.09–6.0 (s, 2H); 13C NMR: δ = 171.87 (C-7), 159.99 
(C-2), 153.00 (C-4), 132.51 (C-6), 107.59 (C-1), 107.53 (C-5), 102.53 (C-3), 
which were neither in agreement with our data, nor in accordance with the 
investigated structure. 
6) Although according to SciFinder, Peng et al. (2004) should have published the 
NMR data of 5-ASA, the paper in question does not contain these data. 
The literature survey on NMR data of anthranilic, 3- and 5-hydroxyanthranilic, 
salicylic, 4- and 5-aminosalicylic acids revealed limited, unassigned or even incorrectly 
assigned spectral data. Our study provided a complete assignment of NMR spectral data 
based on a combination of 
1
H-and 
13
C-NMR 1D- and 2D-experiments and in this way 
bridges the gap existing in the literature with regard to NMR spectral data for these simple 
amino- or/and hydroxy-substituted benzoic acids. 
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132 A. MILTOJEVIĆ, N. RADULOVIĆ 
POTPUNA ASIGNACIJA 
1
H- I 
13
C-NMR SPEKTARA 
ANTRANILNE KISELINE I NJENIH HIDROKSI-DERIVATA 
I SALICILNE KISELINE I NJENIH AMINO-DERIVATA 
U ovom radu dati su NMR podaci za antranilnu (AA), salicilnu (SA) i regioizomerne 
(amino)hidroksibenzoeve kiseline, 3-hidroksiantranilnu (3-HAA), 5-hidroksiantranilnu (5-HAA), 4-
aminosalicilnu (4-ASA) i 5-aminosalicilnu (5-ASA) kiselinu. Kako je pretragom literature utvrđeno 
da su do sada objavljeni NMR podaci za pomenute derivate benzoeve kiseline nepotpuni, 
neasignirani ili čak i pogrešno asignirani, izvršena je kompletna asignacija signala u 1H- i 13C- 
NMR spektrima snimljenim u deuterisanom dimetil-sulfoksidu (DMSO-d6) kombinovanjem 
1H- i 
13C-NMR sa 1H-1H COSY, NOESY, HSQC i HMBC eksperimentima. 
Ključne reči: 1H- i 13C-NMR, 1D- i 2D- NMR, antranilna kiselina, 3- i 5-hidroksiantranilna 
kiselina, salicilna kiselina, 4- i 5-aminosalicilna kiselina 
